Muscle relaxants are a diverse group of medications used to relax or reduce tension in the muscle. Baclofen, methocarbamol, and tizanidine are some of the muscle relaxant drugs that work in the brain or spinal cord to block over-excited neuronal pathways. In contrast, other relaxants, such as dantrolene and botulinum toxin, act directly on the muscle. Muscle relaxants primarily treat two major conditions: spasticity caused by cerebral palsy, multiple sclerosis, and stroke. And, muscle spasms are characteristically temporary and is linked with conditions such as low back pain, tension headache, or fibromyalgia. This disease occurrence is rising and important diagnostic procedures and treatments will boost the growth of the market.
The global muscle relaxant drugs market is expected to witness significant growth during the forecast period. Growing elderly populations globally who are more susceptible to musculoskeletal disorders is the primary factor driving the growth of the market. Muscle relaxants are powerful drugs; though, these can have serious side effects such as heart failure, sedation, and paralysis. In many patients, sedation is reported as the common adverse effect. Therefore, physicians generally advise against driving or operating heavy machinery after muscle relaxant administration. Sudden outbreak of the COVID-19 pandemic imposed stringent lockdown regulations globally, causing interruptions in import and export activities of global muscle relaxant drugs market.
Data Bridge Market Research analyses a growth rate in the global muscle relaxant drugs market in the forecast period 2022-2029. The expected CAGR of global muscle relaxant drugs market is tend to be around 5.2% in the mentioned forecast period. The market was valued at USD 5.94 million in 2021, and it would grow upto USD 8.91 million by 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/global-muscle-relaxant-drugs-market
North America is considered to have the highest lucrative growth in the forecast period due to the rise of surgical procedures performed annually and increased prevalence of spasticity as well as advanced healthcare facilities.
Asia-Pacific is dominating the market due to the increase government initiatives and rapidly aging population.
Key players operating in the global muscle relaxant drugs market include:
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
Novartis AG (Switzerland)
AstraZeneca (U.K.)
Johnson & Johnson Private Limited (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Merck & Co., Inc. (U.S.)
Lilly (U.S.)
Amgen Inc. (U.S.)
Actelion Pharmaceuticals Ltd (Switzerland)
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com